Intrahepatic Oxaliplatin and Systemic 5-FU +/- Cetuximab in Chemo-Na ïve Patients with Liver Metastases from Colorectal Cancer.
CONCLUSIONS: Intrahepatic infusion of oxaliplatin in 10 min with systemic 5-FU to patients with chemo-naïve colorectal cancer is feasible and with low toxicity. A high response rate and long median overall survival were obtained.
PMID: 30999314 [PubMed - as supplied by publisher]
Source: Oncology - Category: Cancer & Oncology Authors: Larsen FO, Jensen BV, Nørgaard HH, Hermann HK, Larsen PN, Markussen A, Hogdall E, Nielsen D Tags: Oncology Source Type: research
More News: Calcium | Cancer | Cancer & Oncology | Chemotherapy | Colorectal Cancer | Eloxatin | Erbitux | Liver | Pain | Toxicology | Urology & Nephrology